According to the Centers for Disease Control and Prevention, overdose deaths fell by 13.9 percent during the 12-month period ending in December 2025 compared to the previous year, reaching a total of 69,973 deaths, the overwhelming majority of which involved fentanyl.
For families trying to decide between rehab centers or weighing treatment options for a loved one, the headline number is encouraging. But researchers say the full picture is more complicated, and it has real implications for how addiction treatment should be approached going forward.
What the New CDC Numbers Actually Show
The decline sounds dramatic, but context matters. Total overdose deaths for the year ending December 2019 were 70,630, almost identical to the current figure.
Researchers at the University of Pittsburgh have noted that overdose deaths grew on an exponential trend line dating back to the late 1970s before the COVID-19 pandemic disrupted it with spikes in overdose deaths, substance use and suicide. The new data may simply reflect a return to that longer-term trajectory rather than a single policy breakthrough.
Younger Generations Are Using Fewer Drugs
One contributing factor is generational. Federally funded surveys including Monitoring the Future have documented long-term declines in adolescent smoking, alcohol use and illicit drug use, while CDC Youth Risk Behavior Survey data show major reductions in teen drinking and smoking over the past two decades. Youth vaping rates have also dropped from their 2019 peak, according to FDA and CDC survey data.
Because most fatal overdoses occur among adults in their 30s through 50s, declining teen use alone doesn’t explain the recent drop.
But it may mean fewer young people progressing into the highest-risk substance use patterns later in life, an important consideration for long-term mental health treatment and prevention planning.
A Shift From Injecting to Smoking Drugs
A less-discussed factor: more people appear to be smoking drugs, particularly fentanyl, instead of injecting them. A CDC study found that by 2022, smoking had overtaken injection as the most commonly documented route of drug use in overdose deaths, while injection-related deaths declined.
Research published in the International Journal of Drug Policy found that people who inject fentanyl face higher nonfatal overdose risk than those who primarily smoke it.
Public health researchers caution this isn’t a safe alternative. Smoking fentanyl remains dangerous and can still be fatal. But some users who developed tolerance to fentanyl have reportedly shifted toward heroin or smoking as supply patterns shift, changes that harm-reduction workers and treatment providers are watching closely as they shape outreach and drug rehab program design.
Europe’s Head Start on Harm Reduction
The US has historically lagged behind much of Europe, where smoking has long been more common than injecting and where overdose death rates have generally stayed lower.
The European Union Drugs Agency reports that injection use has steadily declined across the continent while smoking and inhalation have become more common.
European countries have also relied far more heavily on syringe services, methadone treatment and supervised consumption sites for decades.
In recent years, US states have started catching up. Many have reformed paraphernalia laws to allow fentanyl test strips, some have authorized overdose prevention centers, and the FDA has permitted over-the-counter naloxone sales. These shifts are reshaping the broader addiction treatment landscape, even outside formal rehab settings.
What Isn’t Driving the Decline
According to the report’s author, physician and policy analyst Jeffrey Singer, none of the leading explanations for the decline point to intensified drug enforcement.
He specifically notes that the killing of suspected traffickers in international waters has not been shown to reduce overdose deaths, and argues that if interdiction were meaningfully shrinking supply, illicit drug prices would be rising rather than falling. This is Singer’s analysis and interpretation of the available data, not an official government finding.
What This Means for Treatment Seekers
The decline in overdose deaths doesn’t mean the crisis is over, current numbers are still close to 2019 levels. For people researching rehab, the underlying trends matter more than the headline.
Harm-reduction access, naloxone availability, and treatment that accounts for how someone is using drugs, not just what they’re using, can affect outcomes.
Anyone evaluating addiction treatment options should ask providers how they incorporate harm-reduction principles and medication-assisted treatment (MAT) alongside traditional counseling.
Exploring Treatment Options
If you or someone you love is navigating substance use, the safest path forward usually starts with a clear-eyed comparison of available care. A few practical next steps:
- Compare rehab centers based on levels of care offered, from medical detox through outpatient support
- Understand insurance coverage for rehab before committing to a program, including what’s covered under the Affordable Care Act’s parity requirements
- Ask about evidence-based therapies, including MAT options like buprenorphine and naloxone access planning
- Verify facility credentials, licensing, and accreditation before enrolling
You can explore rehab.com’s directory to find thousands of verified rehab centers. Call
800-985-8516
( 
Sponsored Helpline )
to speak with a treatment advisor.
